Lv1
38 积分 2024-07-29 加入
Slow Coronary Flow: Pathophysiology, Clinical Implications, and Therapeutic Management
8天前
已完结
[The expanding needs on lipid-lowering treatment in patients with acute coronary syndrome by applying newly issued definition of extreme high-risk by Chinese Society of Cardiology]
3个月前
已完结
2024 ESC Guidelines for the management of chronic coronary syndromes
4个月前
已完结
Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double‐blind, placebo‐controlled, phase 3 trial
5个月前
已完结
Henagliflozin as add‐on therapy to metformin in patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double‐blind, placebo‐controlled, phase 3 trial
5个月前
已完结
PCSK9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention: A Randomized, Double- Blind, Placebo-Controlled, Multicenter SHAWN Study
6个月前
已完结
Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases
8个月前
已完结
皖公网安备34019202002308
